These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 11830757)

  • 1. SCH 23390: the first selective dopamine D1-like receptor antagonist.
    Bourne JA
    CNS Drug Rev; 2001; 7(4):399-414. PubMed ID: 11830757
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective dopamine antagonist pretreatment on the antiparkinsonian effects of benzazepine D1 dopamine agonists in rodent and primate models of Parkinson's disease--the differential effects of D1 dopamine antagonists in the primate.
    Gnanalingham KK; Hunter AJ; Jenner P; Marsden CD
    Psychopharmacology (Berl); 1995 Feb; 117(4):403-12. PubMed ID: 7604140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in striatal electroencephalography and neurochemistry induced by kainic acid seizures are modified by dopamine receptor antagonists.
    Bourne JA; Fosbraey P; Halliday J
    Eur J Pharmacol; 2001 Feb; 413(2-3):189-98. PubMed ID: 11226392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. (+/-)-3-[4'-(N,N-dimethylamino)cinnamyl]benzazepine analogs: novel dopamine D1 receptor antagonists.
    Shah JH; Kline RH; Geter-Douglass B; Izenwasser S; Witkin JM; Newman AH
    J Med Chem; 1996 Aug; 39(17):3423-8. PubMed ID: 8765528
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Catalepsy-associated behavior induced by dopamine D1 receptor antagonists and partial dopamine D1 receptor agonists in squirrel monkeys.
    Rosenzweig-Lipson S; Bergman J
    Eur J Pharmacol; 1994 Aug; 260(2-3):237-41. PubMed ID: 7988649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Administration of SCH 23390 into the medial prefrontal cortex blocks the expression of MDMA-induced behavioral sensitization in rats: an effect mediated by 5-HT2C receptor stimulation and not by D1 receptor blockade.
    Ramos M; Goñi-Allo B; Aguirre N
    Neuropsychopharmacology; 2005 Dec; 30(12):2180-91. PubMed ID: 15841107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional differentiation of multiple dopamine D1-like receptors by NNC 01-0012.
    Sugamori KS; Hamadanizadeh SA; Scheideler MA; Hohlweg R; Vernier P; Niznik HB
    J Neurochem; 1998 Oct; 71(4):1685-93. PubMed ID: 9751203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence for dopamine 'D1-like' receptor subtypes in the behavioural effects of two new selective antagonists, LY 270411 and BW 737C.
    Deveney AM; Waddington JL
    Eur J Pharmacol; 1996 Dec; 317(2-3):175-81. PubMed ID: 8997598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SK&F 83822 distinguishes adenylyl cyclase from phospholipase C-coupled dopamine D1-like receptors: behavioural topography.
    O'Sullivan GJ; Roth BL; Kinsella A; Waddington JL
    Eur J Pharmacol; 2004 Feb; 486(3):273-80. PubMed ID: 14985049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impairments of movement initiation and execution induced by a blockade of dopamine D1 or D2 receptors are reversed by a blockade of N-methyl-D-aspartate receptors.
    Hauber W
    Neuroscience; 1996 Jul; 73(1):121-30. PubMed ID: 8783236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of the effects of the D1 receptor antagonists SCH 23390 and SCH 39166 on suppression of feeding behavior by the D1 agonist SKF38393.
    Terry P; Katz JL
    Psychopharmacology (Berl); 1994 Jan; 113(3-4):328-33. PubMed ID: 7862841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Behavioral and neurochemical recovery from partial 6-hydroxydopamine lesions of the substantia nigra is blocked by daily treatment with D1/D5, but not D2, dopamine receptor antagonists.
    Emmi A; Rajabi H; Stewart J
    J Neurosci; 1997 May; 17(10):3840-6. PubMed ID: 9133402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SKF 83959 is an antagonist of dopamine D1-like receptors in the prefrontal cortex and nucleus accumbens: a key to its antiparkinsonian effect in animals?
    Cools AR; Lubbers L; van Oosten RV; Andringa G
    Neuropharmacology; 2002 Feb; 42(2):237-45. PubMed ID: 11804620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dopamine D1 and D2 receptors mediate opposite functions in seizures induced by lithium-pilocarpine.
    Barone P; Palma V; DeBartolomeis A; Tedeschi E; Muscettola G; Campanella G
    Eur J Pharmacol; 1991 Mar; 195(1):157-62. PubMed ID: 1829682
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of the 5-HT1C receptor expressed in Xenopus oocytes by the benzazepines SCH 23390 and SKF 38393.
    Briggs CA; Pollock NJ; Frail DE; Paxson CL; Rakowski RF; Kang CH; Kebabian JW
    Br J Pharmacol; 1991 Dec; 104(4):1038-44. PubMed ID: 1687364
    [TBL] [Abstract][Full Text] [Related]  

  • 16. (+/-)-(N-alkylamino)benzazepine analogs: novel dopamine D1 receptor antagonists.
    Shah JH; Izenwasser S; Geter-Douglass B; Witkin JM; Newman AH
    J Med Chem; 1995 Oct; 38(21):4284-93. PubMed ID: 7473556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Classic D1 dopamine receptor antagonist R-(+)-7-chloro-8-hydroxy-3-methyl-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepine hydrochloride (SCH23390) directly inhibits G protein-coupled inwardly rectifying potassium channels.
    Kuzhikandathil EV; Oxford GS
    Mol Pharmacol; 2002 Jul; 62(1):119-26. PubMed ID: 12065762
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Negative feedback regulation of nigrostriatal dopamine release: mediation by striatal D1 receptors.
    Saklayen SS; Mabrouk OS; Pehek EA
    J Pharmacol Exp Ther; 2004 Oct; 311(1):342-8. PubMed ID: 15175419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dopamine receptor antagonists prevent expression, but not development, of morphine sensitization.
    Jeziorski M; White FJ
    Eur J Pharmacol; 1995 Mar; 275(3):235-44. PubMed ID: 7768290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Substantia nigra D1 receptors and stimulation of striatal cholinergic interneurons by dopamine: a proposed circuit mechanism.
    Abercrombie ED; DeBoer P
    J Neurosci; 1997 Nov; 17(21):8498-505. PubMed ID: 9334422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.